Magalang, Jennifer V.

HRN: 08-69-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/12/2024
10/18/2024
IVT
600mg
Q8
Infected Wound
Waiting Final Action 
10/12/2024
MUPIROCIN 2%, 15G (TUBE)
10/12/2024
10/18/2024
TOPICAL
15g
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: